Susquehanna International Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-439,159
| Closed | -$6.57M | – | 14255 |
|
|
2022
Q4 | $6.57M | Buy |
439,159
+380,259
| +646% | +$5.26M | ﹤0.01% | 2828 |
|
|
2022
Q3 | $485K | Buy |
+58,900
| New | +$452K | ﹤0.01% | 8579 |
|
|
2022
Q2 | – | Sell |
-198,953
| Closed | -$964K | – | 14622 |
|
|
2022
Q1 | $1.11M | Sell |
198,953
-213,045
| -52% | -$878K | ﹤0.01% | 6848 |
|
|
2021
Q4 | $1.93M | Sell |
411,998
-164
| -0% | -$1.02K | ﹤0.01% | 5587 |
|
|
2021
Q3 | $2.55M | Buy |
412,162
+157,092
| +62% | +$940K | ﹤0.01% | 5309 |
|
|
2021
Q2 | $1.68M | Buy |
255,070
+236,359
| +1,263% | +$1.63M | ﹤0.01% | 6323 |
|
|
2021
Q1 | $137K | Sell |
18,711
-71,698
| -79% | -$619K | ﹤0.01% | 11709 |
|
|
2020
Q4 | $522K | Sell |
90,409
-18,034
| -17% | -$103K | ﹤0.01% | 8193 |
|
|
2020
Q3 | $644K | Buy |
108,443
+10,588
| +11% | +$52.4K | ﹤0.01% | 7137 |
|
|
2020
Q2 | $504K | Buy |
97,855
+42,943
| +78% | +$271K | ﹤0.01% | 7343 |
|
|
2020
Q1 | $199K | Sell |
54,912
-9,677
| -15% | -$48K | ﹤0.01% | 8706 |
|
|
2019
Q4 | $403K | Sell |
64,589
-71,056
| -52% | -$523K | ﹤0.01% | 7415 |
|
|
2019
Q3 | $1.15M | Buy |
135,645
+26,946
| +25% | +$201K | ﹤0.01% | 5403 |
|
|
2019
Q2 | $732K | Buy |
+108,699
| New | +$931K | ﹤0.01% | 6411 |
|
|
2019
Q1 | – | Sell |
-27,208
| Closed | -$281K | – | 10353 |
|
|
2018
Q4 | $435K | Buy |
+27,208
| New | +$599K | ﹤0.01% | 6301 |
|
|
2018
Q2 | – | Sell |
-73,291
| Closed | -$1.74M | – | 10809 |
|
|
2018
Q1 | $2.13M | Buy |
73,291
+44,022
| +150% | +$1.29M | ﹤0.01% | 3802 |
|
|
2017
Q4 | $817K | Buy |
+29,269
| New | +$909K | ﹤0.01% | 5646 |
|
|
2017
Q1 | – | Sell |
-23,470
| Closed | -$127K | – | 10478 |
|
|
2016
Q4 | $127K | Buy |
+23,470
| New | +$156K | ﹤0.01% | 8962 |
|
|
2016
Q3 | – | Sell |
-9,540
| Closed | -$92K | – | 9344 |
|
|
2016
Q2 | $92K | Buy |
9,540
+3,080
| +48% | +$29.7K | ﹤0.01% | 8060 |
|
|
2016
Q1 | $59K | Buy |
6,460
+3,299
| +104% | +$32.7K | ﹤0.01% | 8622 |
|
|
2015
Q4 | $40K | Sell |
3,161
-3,661
| -54% | -$43.5K | ﹤0.01% | 9144 |
|
|
2015
Q3 | $83K | Buy |
6,822
+5,259
| +336% | +$76K | ﹤0.01% | 9221 |
|
|
2015
Q2 | $27K | Sell |
1,563
-8,547
| -85% | -$154K | ﹤0.01% | 9967 |
|
|
2015
Q1 | $147K | Buy |
10,110
+659
| +7% | +$7.2K | ﹤0.01% | 8816 |
|
|
2014
Q4 | $79K | Sell |
9,451
-1,415
| -13% | -$12.9K | ﹤0.01% | 9262 |
|
|
2014
Q3 | $121K | Buy |
10,866
+5,565
| +105% | +$70.7K | ﹤0.01% | 9016 |
|
|
2014
Q2 | $97K | Buy |
5,301
+3,787
| +250% | +$49.3K | ﹤0.01% | 9435 |
|
|
2014
Q1 | $23K | Buy |
1,514
+231
| +18% | +$4.15K | ﹤0.01% | 8779 |
|
|
2013
Q4 | $24K | Sell |
1,283
-4,897
| -79% | -$98.1K | ﹤0.01% | 8889 |
|
|
2013
Q3 | $128K | Sell |
6,180
-1,827
| -23% | -$41.8K | ﹤0.01% | 7985 |
|
|
2013
Q2 | $200K | Buy |
+8,007
| New | +$342K | ﹤0.01% | 7431 |
|
Susquehanna International Group's AVEO Position: Q1 2023 in Review
Susquehanna International Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 439,159 shares — an estimated $6.57M sold.
Susquehanna International Group first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $6.57M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Susquehanna International Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group sold 439,159 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6.57M.
- Susquehanna International Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
- Susquehanna International Group's AVEO Pharmaceuticals, Inc. position peaked at $6.57M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.